Scientific literature monitoring & KOL identification
- Extract and organize content from the literature and databases to learn from research around your target indication or molecule
- Supplement and enhance your searches with fully integrated information on companies and research institutes, current biomedical literature and the most recent patient literature
- Identify the key opinion leaders who can provide advice around drug development or clinical trial planning
Assess the literature landscape and identify KOLs
Molecular pathway analysis & bioinformatics
- Understand the meaning of your omics data in the context of healthy and diseased molecular pathways
- Link drugs, targets and genes to biomarker information from a diverse range of sources
- Rapidly generate and validate hypotheses for novel biomarkers, targets and mechanisms of action
Analyze molecular pathways and accelerate discovery research
Preclinical drug development
- Compare your drug’s preclinical performance to prior research
- Access scientific pipeline data that are easily searchable in one platform
- Help drive innovation and support earlier decision-making when developing new hypotheses for new targets, drugs and biomarkers
- Learn from the success of your peers with comprehensive coverage of pipeline data, patents, literature and conferences – all from a scientific perspective
Get biology, chemistry and pharmacology data – all in one place
Clinical trial planning & feasibility
- Understand the successful protocols, sites or patient segments for drugs in your therapeutic area
- Generate testable hypotheses for patient stratification, biomarker discovery, disease understanding, target identification, drug combination effect prediction and drug repositioning
- Explore disease therapy areas, interventions, phases, recruitment status, start and end dates, sites, sponsors and collaborators, actions and drug classes, patient segment and eligibility criteria, inclusion criteria including gene variants, biomarkers, endpoints, combination therapies, trial designs, results and adverse events
Get detailed insights on clinical sites and trial protocols
Regulatory intelligence, compliance & monitoring
- Compile and understand the latest regulations in your target countries/regions
- Quickly understand regulatory requirements across all aspects of therapy development
- Prepare for inspections, understand trends in drug approvals and discern submission requirements and instructions
- Conduct pre- and post-marketing surveillance and understand approvals
Confidently navigate the regulatory landscape
Safety & toxicology intelligence
- Identify toxicity and safety events commonly seen in your drug class and benchmark the safety profile of competitor compounds.
- Correlate preclinical and clinical pharmacological evidence to anticipate and track potential adverse events as clinical trials begin and plan risk mitigation.
- Monitor regulatory concerns and assess label information from FDA, EMA and PMDA to anticipate potential contingencies based on the assessment of similar therapies.
- Optimize risk management planning with an integrated view of FAERS, JADER and other manually curated safety data to identify and assess potential pharmacovigilance signals.
Contact us
